Breast Cancer Therapeutics Market

1. Breast Cancer Therapeutics Market Global Key Players, Trends, Share, Industry Size, Segmentation, Forecast To 2030 Cancer is essentially the uncontrolled growth of certain cells in the body that crowd out normal cells over time. When cells in the breast begin to grow out of control it may lead to breast cancer. These cells generally form a tumor that can felt as a lump, which can further be confirmed using a mammogram. The tumor is malignant if the cells can grow into surrounding tissues or spread to other parts of the body. Breast cancer occurs almost entirely in women, though men can also contract breast cancer. Mutations in DNA can cause normal breast cells to become cancerous cells. Some DNA changes are passed on from parents and can significantly increase the threat for breast cancer. The global Breast Cancer Therapeutics market was pegged at US$ 24.68 billion in 2021. The market is expected to witness a CAGR of 13.80 % from 2022 to 2030. Globally breast cancer is the most common cancer in women, with a prevalence of around 1.7 million in 2012, the second-most common cancer overall. This represents 12% of all new cancer cases and 25% of all cancers in women. Belgium had the topmost rate of breast cancer, followed by Denmark and France, respectively. Marginally less number of cases of breast cancer were diagnosed in less developed countries. The highest occurrence of this type of cancer was in Northern America and Oceania, whereas the lowest incidence rate in Asia and Africa. To access the Sample PDF of this research study, please request here: https://growthplusreports.com/inquiry/request-sample/breast-cancer- therapeutics-market/7993 Key Players: Novartis AG Pfizer Inc Oncogenex Apthera Inc Astellas BioNumerik Pharmaceuticals Oncothyreon Inc Bipar Sciences Eli Lilly and Company Novartis AG

2. AstraZeneca Plc Sanofi Merck & Co., Inc Bristol Myers Squibb Breast Cancer Therapeutics Market by Therapy Type Targeted Therapy Hormonal Therapy Chemotherapy Immunotherapy by Cancer Type Hormone Receptor HER2+ Triple Negative Browse the full report now: https://growthplusreports.com/report/breast- cancer-therapeutics-market/7993 About Us: Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.